Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Haematologica
|
December 28, 2019
Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation
Eva Wagner-Drouet, Daniel Teschner, Christine Wolschke, et al.
Bone Marrow Transplantation
|
September 7, 2023
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
Juan Carlos Hernández-Boluda, Diderik-Jan Eikema, Linda Koster, et al.
Bone Marrow Transplantation
|
December 24, 2025
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm
Alexandros Rampotas, Jose Maria Aspa-Cilleruelo, Linda Koster, et al.
Bone Marrow Transplantation
|
March 7, 2026
Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study
Malgorzata Mikulska, Gloria Tridello, Per Ljungman, et al.
American Journal of Hematology
|
May 26, 2022
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial
Dietrich W Beelen, Matthias Stelljes, Péter Reményi, et al.
American Journal of Hematology
|
March 21, 2026
Decreased Chronic GvHD With Post-Transplant Cyclophosphamide Versus ATG in Patients With Myelofibrosis Allografted With an Unrelated Donor: A Study From the Chronic Malignancies Working Party of the EBMT
Yves Chalandon, Edouard F Bonneville, Diderik-Jan Eikema, et al.
Nature Cancer
|
January 3, 2024
Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation
Erik Thiele Orberg, Elisabeth Meedt, Andreas Hiergeist, et al.
The Journal of Clinical Investigation
|
May 9, 2023
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors
Agnes Bonifacius, Britta Lamottke, Sabine Tischer-Zimmermann, et al.
Blood Cancer Journal
|
October 5, 2021
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
Christina Rautenberg, Friedrich Stölzel, Christoph Röllig, et al.
Blood Cancer Journal
|
April 8, 2025
Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients
Christina Rautenberg, Jan Moritz Middeke, Christoph Röllig, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Haematologica
|
December 28, 2019
Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation
Eva Wagner-Drouet, Daniel Teschner, Christine Wolschke, et al.
Bone Marrow Transplantation
|
September 7, 2023
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
Juan Carlos Hernández-Boluda, Diderik-Jan Eikema, Linda Koster, et al.
Bone Marrow Transplantation
|
December 24, 2025
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm
Alexandros Rampotas, Jose Maria Aspa-Cilleruelo, Linda Koster, et al.
Bone Marrow Transplantation
|
March 7, 2026
Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study
Malgorzata Mikulska, Gloria Tridello, Per Ljungman, et al.
American Journal of Hematology
|
May 26, 2022
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial
Dietrich W Beelen, Matthias Stelljes, Péter Reményi, et al.
American Journal of Hematology
|
March 21, 2026
Decreased Chronic GvHD With Post-Transplant Cyclophosphamide Versus ATG in Patients With Myelofibrosis Allografted With an Unrelated Donor: A Study From the Chronic Malignancies Working Party of the EBMT
Yves Chalandon, Edouard F Bonneville, Diderik-Jan Eikema, et al.
Nature Cancer
|
January 3, 2024
Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation
Erik Thiele Orberg, Elisabeth Meedt, Andreas Hiergeist, et al.
The Journal of Clinical Investigation
|
May 9, 2023
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors
Agnes Bonifacius, Britta Lamottke, Sabine Tischer-Zimmermann, et al.
Blood Cancer Journal
|
October 5, 2021
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
Christina Rautenberg, Friedrich Stölzel, Christoph Röllig, et al.
Blood Cancer Journal
|
April 8, 2025
Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients
Christina Rautenberg, Jan Moritz Middeke, Christoph Röllig, et al.
Page
of 7